Bariatric surgery appears to induce changes in the gastrointestinal tract and its interactions with the endocrine system in ways that may influence glycemic control.
Researchers examined how adipocyte size reduction and fatty acid metabolism contribute to remission in type 2 diabetes following bariatric surgery.
According to recent research published in JAMA Surgery, bariatric surgery at body mass index less than 40 kg/m² tends to achieve better results.
Further investigation is needed to examine the mechanism behind aspirin responsiveness following bariatric surgery.
Researchers followed 2218 patients from across the US who underwent bariatric surgery and were prescribed an opioid.
A significant interaction occurred between baseline glycemic status and treatment effect on microvascular disease incidence.
For obese patients with type 2 diabetes, bariatric surgery is associated with improved splanchnic vascular responses.
A patient notes concerns with vision difficulty 4 years after undergoing a laparoscopic biliopancreatic diversion with a duodenal switch.
There are fewer cases of incident diabetic retinopathy among obese patients with type 2 diabetes undergoing bariatric surgery compared with medical treatment.
Severely obese adolescents who underwent gastric bypass surgery experienced significant weight loss that was maintained over long-term follow-up.
Gastric bypass, but not gastric banding, is associated with reduced risk of psoriasis, progression to severe psoriasis, and psoriatic arthritis.
Although glucose control is initially superior following Roux-en-Y gastric bypass vs laparoscopic adjustable gastric banding, greater weight loss may attenuate this effect.
Bariatric surgery was associated with a significant reduction in risk of heart failure among obese patients.
Patients who undergo Roux-en-Y gastric bypass are less likely to die from obesity or other diseases than those who did not undergo the procedure 10 years later.
In a study of Swedish Obese Subjects participants, researchers found that bariatric surgery provided benefits above and beyond usual care for weight loss.
Women experienced weight loss as well as decreases in ovarian volume and markers of androgen excess.
Women with a history of bariatric surgery may have an increased risk of preterm birth.
Researchers reported improvements in hepatic insulin sensitivity, endogenous glucose production, and lipolysis.
A patient came to the clinic to discuss her dizzy spells 4 years after her Roux-en-Y gastric bypass surgery.
Much of the weight lost via bariatric surgery appears to stay off for at least 10 years, according to a study published online in JAMA Surgery.
Watch Christopher Thompson, MD, of Brigham and Women's Hospital, explain the minimally invasive endoscopic sleeve gastroplasty procedure for weight loss.
Pregnant women who have had bariatric surgery may have increased odds for premature delivery.
Preoperative clinical factors, such as insulin use or a history of smoking, are linked to greater long-term weight loss after gastric bypass.
Allison Goldfine, MD, discusses how bariatric surgery may help patients with type 2 diabetes achieve disease remission.
Patients undergoing bariatric surgery were more likely to fracture than obese or non-obese controls.
A study recently examined the mechanisms behind the reduction in serum uric acid levels following weight loss in obese patients.
Altered physiology of adipose tissue has specific effects on various fat depots.
Forty-five professional groups say the procedure improves blood glucose control and should be considered.
Diabetic ketoacidosis should be considered in patients with type 2 diabetes who present soon after bariatric surgery.
An array of changes in protein abundance in skeletal muscle were observed before and after RYGB surgery.
Endocrinology Advisor Articles
- Imaging Studies in Hypothyroidism Evaluation Linked to Unnecessary Risks
- Insulin Glargine Associated With Breast Cancer Risk in T2D
- Transoral Endoscopic Thyroidectomy Vestibular Approach: Safety and Outcomes
- Once-Weekly Omarigliptin Improves Glycemic Control in Type 2 Diabetes
- Improving Vascular Function in Pediatric T1D With Metformin
- Update on Vitamin D and Calcium Supplements for Reducing Fracture Risk
- Lower Risk for SGLT2i-Associated Genitourinary Infection With DPP-4i
- Severe Hypoglycemia Associated With Increased Mortality Risk in T2D
- Efficacy of CGM in Preterm Infants of Mothers With Diabetes
- SSRIs and SNRIs Linked to Type 2 Diabetes in Children, Adolescents
- Increased Risk of Diabetes, Post-Diabetes Pneumonia for Patients With COPD
- Pancreatic Exocrine Dysfunction Occurs After Islet Autoimmunity in T1D
- T2D in African American Women Ups ER-negative Breast Cancer Risk
- High-Sensitivity CRP and LDL-C Predictive of Subsequent MACE in T2D
- Risks Associated With Denosumab Discontinuation